title: Deletion of 11q23 is a highly specific nonrandom secondary genetic abnormality of ETV6/RUNX1-rearranged childhood acute lymphoblastic leukemia.
authors.forename: A
authors.initials: A
authors.lastname: Attarbaschi
authors.forename: G
authors.initials: G
authors.lastname: Mann
authors.forename: S
authors.initials: S
authors.lastname: Strehl
authors.forename: M
authors.initials: M
authors.lastname: König
authors.forename: M
authors.initials: M
authors.lastname: Steiner
authors.forename: V
authors.initials: V
authors.lastname: Jeitler
authors.forename: Th
authors.initials: T
authors.lastname: Lion
authors.forename: M N
authors.initials: MN
authors.lastname: Dworzak
authors.forename: H
authors.initials: H
authors.lastname: Gadner
authors.forename: O A
authors.initials: OA
authors.lastname: Haas
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001317:Austria / Q000453:epidemiology; D014408:Biomarkers, Tumor / Q000235:genetics*; D002051:Burkitt Lymphoma / Q000453:epidemiology / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D002872:Chromosome Deletion; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics / Q000648:ultrastructure*; D015331:Cohort Studies; D050676:Core Binding Factor Alpha 2 Subunit / Q000235:genetics*; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007621:Karyotyping; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics*; D000097764:ETS Translocation Variant 6 Protein
chemical_list: D014408:Biomarkers, Tumor; D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; C102421:TEL-AML1 fusion protein; D000097764:ETS Translocation Variant 6 Protein